Spend enough time with another person, and you begin to pick up their mannerisms. Such behavioral "synchronization" is a mechanism by which we build social cohesion. But what about across species? Turns out, at least as dogs are concerned, researchers found that they are in tune with their owners.

A new study in the British Medical Journal suggests that the majority of new cancer drugs approved by the European Medicines Agency lacked evidence that they improved survival or the quality of life of patients.

Cirrhosis, the final stage of liver disease, is the 12th leading cause of death in the United States. Unhealthy bacteria in the mouth and gut appear to play a role.

Warning letters by the United States Food and Drug Administration (FDA) can be interesting to read. A recent one, from the end of September, is more interesting than most.
The facilities of Nashoba Brook Bakery, located in Concord, MA, were inspected by the FDA and a number of violations were found and documented. Actually, to be clear, Nashoba Brook Bakery was found to be - in one phrase - a hot mess. 

We get it. The actress hates guns. But please don’t use your high visibility to spread untruths about the medical profession, just to make a political point.

A working group with the American Association for the Advancement of Science released a new report stating that any claim of precision in identifying a specific person from a fingerprint is "indefensible" and has no scientific foundation.

A Detroit mother was sentenced to seven days in jail for failing to comply with a judge's orders to vaccinate her son, as she had agreed to do in her divorce agreement. Falsely claiming a religious exemption, this woman is now a martyr for anti-vaccine propagandists.

We often come across studies reporting that a diet or food is helpful, but shortly thereafter finding another stating the effect is either non-existent or even detrimental. So what's a person to believe? Strangely, sometimes both claims can turn out to be true – at least that might well be the case for soybeans and breast cancer.

When Sovaldi, the first in a family of drugs that cured hepatitis C came out, its maker Gilead came under fire for the price of the drug: $1,000 per pill x 84 pills. Now we have eight more direct-acting antivirals for hep C. They are not only getting better, but also cheaper. Competition in the pharmaceutical industry benefits all of us. 

Researchers from Georgetown University recently published a study in the journal Tobacco Control demonstrating the potential to save millions of people from premature smoking-related deaths by switching to e-cigarette use.